Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/04/20/2651112/0/en/Biostax-Corp-and-Statera-Biopharma-Inc-reach-mutually-beneficial-dispute-settlement-and-amended-license-agreement-providing-clearer-clinical-and-commercial-pathways-for-both-compan.html
https://www.globenewswire.com/news-release/2023/03/15/2627590/0/en/Statera-Biopharma-Signs-Letter-of-Intent-for-Merger-with-Worksite-Labs.html
https://www.accesswire.com/722713/Statera-Biopharma-Receives-Positive-Nasdaq-Listing-Determination
https://www.accesswire.com/721696/Statera-Biopharma-Files-Form-10-Q-and-Reaches-Agreement-with-Silverback-Capital-and-AVOF
https://www.accesswire.com/720710/Statera-Biopharma-Announces-Signing-of-a-Binding-MOU-with-Holobeam-Technologies-to-Gain-Access-to-Holobeams-Disruptive-Diagnostic-Imaging-and-Therapeutic-Technology-for-Cancer-Patients
https://www.accesswire.com/715457/Statera-Biopharma-Receives-Nasdaq-Listing-Determination-Hearing-Requested-to-Address-Filing-Delinquency
https://www.globenewswire.com/news-release/2022/06/14/2462020/0/en/Statera-Biopharma-Announces-BF-Borgers-CPA-PC-as-Independent-Registered-Public-Accounting-Firm.html
https://www.globenewswire.com/news-release/2022/05/23/2448764/0/en/Statera-Biopharma-Receives-Notification-Letter-from-Nasdaq-Regarding-Form-10-Q-Filing.html
https://www.globenewswire.com/news-release/2022/05/13/2442928/0/en/Statera-Biopharma-and-Lay-Sciences-Inc-Announce-Intent-to-Enter-Strategic-Partnership-to-License-the-Manufacturing-Rights-to-Certain-Lay-Sciences-IgY-Products.html
https://www.globenewswire.com/news-release/2022/04/27/2430707/0/en/Statera-Biopharma-and-Immune-Therapeutics-Inc-Announce-Strategic-Agreement-for-Rights-to-Low-Dose-Naltrexone.html